Reduction of adhesion formation by intraperitoneal administration of various anti-inflammatory agents

Journal of Investigative Surgery

Volumn 11, Issue 5, 1998, Pages 327-339

  Rodgers, Kathleen E ^a   Girgis, Wefki ^a   Amand, Karen St ^a   Campeau, Joseph D ^a   DiZerega, Gere S ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Adhesions; Anti inflammatory; Dipyridamole; Peritoneal; Quinacrine; Retinoid

Indexed keywords

ANTIINFLAMMATORY AGENT; DIPYRIDAMOLE; MEPACRINE; RETINOIC ACID;

ABDOMINAL INJURY; ANIMAL MODEL; ARTICLE; CECUM; FEMALE; INTESTINE; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; OSMOTIC MINIPUMP; PERITONEUM ADHESION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RABBIT; UTERUS HORN;

EID: 0031767499     PISSN: 08941939     EISSN: None     Source Type: Journal    
DOI: 10.3109/08941939809032209     Document Type: Article

References (74)

1. diZerega G, Rodgers KE. Intraperitoneal adhesions. In: The Peritoneum. New York: Springer-Verlag; 1992:274-306.
2. Thorton M, diZerega GS. Use of barriers in adhesion prevention. Contemp. OB/GYN. 1996;41:201-214.
3. Ellis H. Intestinal Obstruction. New York: Appleton-Century-Crofts; 1982.
4. Menzies D. Peritoneal adhesions - incidence, cause, and prevention. Surg Annu. 1992;24:27-45.
5. Menzies D, Ellis H. Intestinal obstruction from adhesions - How big is the problem? Ann R Coll Surg Engl. 1990; 72:62-63.
6. DeCherney AH, diZerega GS. Clinical problems intraperitoneal postsurgical adhesion formation following general surgery and the use of adhesion prevention barriers. Surg Clin North Am. 1997;77:671-688.
7. Scott Coombes DM, Vipond MN, Thompson JN. General Surgeon's attitude to the treatment and prevention of abdominal adhesions. Ann R Coll Surg Engl. 1993;75:123-128.
8. Blanco J. Bowel obstruction related to prior gynecologic surgery. In: Pelvic Surgery - Adhesion Formation and Prevention. New York: Springer-Verlag; 1997:160.
9. Federmann G, Walenzyk J, Schneider A, Scheele C, Bauermeister G. Efficacy of laparoscopy in treatment of acute small bowel obstruction caused by adhesions. In: Peritoneal Adhesions. New York: Springer-Verlag; 1997; 291.
10. Treutner KH, Bertram P, Latzsch G, Schumpelick V. Causes of interstinal obstruction - A retrospective study of 550 surgical cases. In: Treutner KH, Schumpelick V, eds. Peritioneal Adhesions. New York: Springer-Verlag; 1997:1991.
11. Schoffel U, Sendt W, Haring R, Fathmann EH. Indications and therapeutic strategy for intestinal obstruction due to intra-abdominal adhesions. In: Treutner KH, Schumpelick V, eds. Peritoneal Adhesions. New York: Springer-Verlag; 1997;271.
12. Ratcliff JB, Kapernick P, Brook GG, et al. Small bowel obstruction of gynecologic surgery. South Med J. 1983; 76:1349-1360.
13. Strickler B, Blanco J, Fox HE. The gynecologic contribution to intestinal obstruction in females. J Am Coll Surg. 1994; 178:617.
14. Stout AL, Steege JF, Dodson WC, Hughes CL. Relationship of laparoscopic findings to self-report of pelvic pain. Am J Obstet Gynecol. 1991;146:73.
15. Howard FM. The role of laparoscopy in chronic pelvic pain: Promise and pitfalls. Obstet Gynecol Surv. 1993;48: 357.
16. Peters AAW, Trimbos-Kemper TCM, Admiraal C, et al. A randomized clinical trial on the benefit of adhesiolysis in patients with intraperitoneal adhesions and chronic pelvic pain. Br J Obstet Gynaecol. 1992;99:59.
17. DeCherney AH, Mezer HC. The nature of post-tuboplasty pelvic adhesions determined by early and late laparoscopy. Fertil Steril. 1984;41:643.
18. Trimbos-Kemper TCM, Trimbos JB, van Hall, EV. Adhesion formation after tubal surgery results of the eight-day laparoscopy in 188 patients. Fertil Steril. 1985;43:396.
19. Duffy DM, diZerega GS. Is peritoneal closure necessary? Obstet Gynecol Surv. 1994;49:817-822.
20. Marana R, Rizzi M, Ludovico M. Adhesions and infertility. In: diZerega GS, de Chevney AH, Diamond MP, Dunn RC, Goldberg EP, Haney AF, Rock JA, Tulandis T, Rodgers KE, eds. Pelvic Surgery - Adhesion Formation and Prevention. New York: Springer-Verlag; 1997:126.
21. Lundorff P. Infertility and ectopic pregnancy. In: diZerega GS, de Chevney AH, Diamond MP, Dunn RC, Goldberg EP, Haney AF, Rock JA, Tulandis T, Rodgers KE, eds. Pelvic Surgery - Adhesion Formation and Prevention. New York: Springer-Verlag; 1997:144.
22. Bakkum E, Peters AAW. Clinical significance of adhesion in patients with chronic pelvic pain. In: diZerega GS, de Chevney AH, Diamond MP, Dunn RC, Goldberg EP, Haney AF, Rock JA, Tulandis T, Rodgers KE, eds. Pelvic Surgery - Adhesion Formation and Prevention. New York: Springer-Verlag; 1997:150.
23. diZerega G, Rodgers KE. Prevention of postoperative adhesions. In: The Peritoneum. New York: Springer-Verlag; 1992:307-370.
24. diZerega GS. 1994. Contemporary adhesion prevention. Fertil Steril. 1994;61:219-235.
25. Adhesion Study Group. Reduction of post operative pelvic adhesions with intraperitoneal 32% dextran 70: A prospective, randomized clinical trial. Fertil Steril. 1983; 40:612-619.
26. Thornton MH, Campeau JD, diZerega GS. Use of adhesion prevention barriers in gynecological surgery. In: Treutner KH, Schumpelick V, eds. Peritoneal Adhesions. New York; Springer-Verlag: 1997:370.
27. diZerega GS. Use of adhesion prevention barriers in pelvic reconstructive and gynecologic surgery. In: diZerega GS, de Chevney AH, Diamond MP, Dunn RC, Goldberg EP, Haney AF, Rock JA, Tulandis T, Rodgers KE, eds. Pelvic Surgery - Adhesion Formation and Prevention. New York: Springer-Verlag; 1997:188.
28. diZerega GS. Use of adhesion prevetion barriers in ovarian surgery tubalplasty ectopic pregnancy, endometriosis, adhesiolysis, and myomectomy. Curr Opin Obstet Gynecol. 1996;8:230-237.
29. Treutner KH, Bertram P, Loser S, et al. Prophylaxe und Therapie intraabdomineller adhasionen - Eine umfrage an 1200 Kliniken in Deutschland. Chirurg. 1995;66:398-403.
30. Rodgers KE, Bracken K, Cox G, Richer L, Girgis W, diZerega GS. Inhibition of post surgical adhesions by liposomes containing anti-inflammatory drugs. Int J Fertil. 1990;35(5):315.
31. Rodgers K, Girgis W, Johns D, diZerega G. Intraperitoneal tolmetin prevents postsurgical adhesion formation in rabbits. Int J Infertil. 1990;35:40-45.
32. Rodgers KE, Ellefson DD, Girgis W, diZerega GS. Modulation of postsurgical cell infiltration and fibriolytic activity by tolmetin in two species. J Surg Res. 1994;56:314-325.
33. LeGrand EK, Rodgers KE, Girgis W, Campeau JD, diZerega GS. Comparative efficacy of nonsteroidal anti-inflammatory drugs and anti-thromboxane agents in a rabbit adhesion prevention model. J Invest Surg. 1995; 8:187-194.
34. Rodgers KE, Girgis W, Campeau JD, diZerega GS. Reduction of adhesion formation by intraperitoneal administration of a recombinant hirudin analog. J Invest Surg. 1996; 9:388-391.
35. Rodgers KE, Girgis W, Campeau JD, diZerega GS. Reduction of adhesion formantion by intraperitoneal administration of anti-inflammatory peptide 2. J Invest Surg. 1997;10:31-36.
36. Rodgers KE, Johns D, diZerega GS. Prevention of adhesion formation after intraperitoneal administration of tolmetin and hyaluronic acid. J Invest Surg. in press.
37. Mehta K, McQueen T, Tucker S, Pandita R, Aggarwal BB. Inhibition by all-trans-retinoic acid of tumor necrosis factor and nitric oxide production by peritoneal macrophages. J Leukocyte Biol. 1994;44: 336-342.
38. Olansky AJ. Antimalarials and ophthalmologic safety. J Am Acad Dermatol. 1982;6:19-23.
39. Fitch CD. Mode of action of antimalarial drugs. CIBA Foundation Symp. 1983;94:222-232.
40. Beckman A, Seferynska F. Possible involvement of phospholipase activation in erythroid progenitor cell proliferation. Exp Hematol. 1989;17:309-312.
41. 2. J Clin Invest. 1993;91:2118-2125.
42. Stacey NH, Klaassen CD. Effects of phospholipase A2 inhibitors on diethyl maleate-induced lipid peroxidation and cellular injury in isolate rat hepatocytes. J Toxicol Environ Health. 1982;9:439-450.
43. O'Rourke AM, Mescher MF, Apgar JR. IgE receptor-mediated arachidonic acid release by rat basophilic leukemia (RBL-2H3) cells: Possible role in activating degranulation. Mol Immunol. 1992;29:1299-1308.
44. Randall RW, Eakins KE, Higgs GA. Inhibition of arachidonic acid cyclooxygenase and lipooxygenase activities by indomethacin and compound BW755. Agents Actions. 1980;10:553-555.
45. Golan A, Stolik O, Wexler S, Lander R, Ber A, David MP. Prostaglandins - A role in adhesion formation. An experimental study. Acta Obstet Gynecol Scand. 1990;69:339-341.
46. Golan A, Bernstein T, Wexler S, Neuman M, Bukovsky I, David MP. The effect of prostaglandins and aspirin: An inhibitor of prostaglandin synthesis on adhesion formation in rats. Human Reprod. 6:251-254.
47. Mammen, EF. An overview of dipyridamole. Thromb Res Suppl. 1990;XIII:1-10.
48. Boeynaems JM, Van-Coevorden A, Demolle D. Dipyridamole and vascular prostacyclin production. Biochem Pharmacol. 1986;35:2897.
49. Tzanakakis GN, Agarwal KC, Vezeredis MP. Prevention of human pancreatic cancer cell-induced hepatic metastasis in nude mice by dipyridamole and its analog RA-233. Cancer. 1993;71:2466.
50. Constantini V, Talpacci A, Bastino ML, Boschetti E, Cipolloni S, Bisacci R, Nenci GG. Increased prostacyclin production from human veins by dipyridamole: An in vitro and ex vitro study. Biomed Biochim Acta. 1991;49: 263.
51. Nishimura K, Shimanuki T, diZerega GS. The use of ibuprofen for the prevention of postoperative adhesions in rabbits. Am J Med. 1984;77:102-106.
52. Zitnik, Kotloff RM, Latifpour J, Schwalb J, Zheng T, Whiting NL, Elias JA. Retinoic acid inhibition of IL-1 induced IL-6 production by human lung fibroblasts. J Immunol. 1994;152:1419-1427.
53. Schuster PA, Medcalf RL, Kruithof EKO. Retinoic acid potentiates phorbol ester-mediated induction of urokinase and plasminogen activator inhibitor type 2 in human myeloid leukemic cell lines. Endocrinology. 1993;133: 1724-1730.
54. Immonen R, Siren V, Stephens RW, Liesto K, Vaheri A. Retinoids increase urokinase-type plasminogen activator production by human retinal pigment epithelial cells in culture. Invest Ophthal Visual Sci. 1993;34:2062-2067.
55. van Giezen JJJ, Boon GIA, Jansen JWCM, Bouma BN. Retinoic acid enhances fibrinolytic activity in vivo by enhancing tissue type plasminogen activator (tPA) activity and inhibits venous thrombosis. Thromb Haemostasis. 1993;69:381-386.
56. Medh RD, Santell L, Levin EG. Stimulation of tissue plasminogen activator production by retinoic acid: Synergistic effect on protein kinase C-mediated activation. Blood. 1992;80(4):981-987.
57. Van Bennekum AM, Emeis JJ, Kooistra T, Hendriks HF. Modulation of tissue type plasminogen activator by retinoids in rat plasma and tissues. Am J Physiol. 1993; 264(5):R931-R937.
58. Conese M, Montemurro P, Fumarulo R, Giordano D, Riccardi S, Colucci M, Semeraro N. Inhibitory effects of retinoids on the generation of procoagulant activity by blood mononuclear phagocytes. Thromb Haemostasis. 1991;66:662-665.
59. Horie S, Kizaki K, Ishii H, Kazama M. Retinoic acid stimulates expression of thrombomodulin, a cell surface anticoagulant glycoprotein, on human endothelial cells. Biochem J. 1993;281:149-154.
60. Ishii H, Horie S, Kizaki K, Kazama M. Retinoic acid counteracts both the downregulation of thrombomodulin and the induction of tissue factor in human endothelial cells exposed to tumor necrosis factor. Blood. 1992;80:2556-2562.
61. Mumford D, Kessel SJ. Sterilization needs in the 1990s: The case for quinacrine nonsurgical female sterilization. Am J Obstet Gynecol. 1992;167:1203-1207.
62. 2-induced oedema in rat skin and histamine release in rat mast cells. Evidence for involvement of lysophospholipids in the mechanism of action. Agents Actions. 1992;36:258-263.
63. 4 formation and fMLP binding. J Leukocyte Biol. 1992;52:545-550.
64. Prowse C, Pepper D, Dawes J. Prevention of the platelet alpha-granule reaction by membrane active drugs. Thromb Res. 1982;25:219-227.
65. Raftery AT. Effect of peritoneal trauma on peritoneal fibrinolytic activity and intraperitoneal adhesion formation. Eur Surg Res. 1981;13:397-401.
66. Buckman RF, Buckman PD, Hufnagel HV, Gervin AS. A physiologic basis for the adhesion-free healing of deperitonealized surfaces. J Surg Res. 1976;21:67-76.
67. Saniabadi AR, Fisher TC, McLaren M, Belch JF, Forbes CD. Effect of dipyridamole alone and in combination with aspirin on whole blood platelet aggregation, PGb generation, and red cell deformability ex vivo in man. Cardiovasc Res. 1991;25:177.
68. Gryglewski RJ. Prostaglandins, platelets, and atherosclerosis. CRC Crit Rev Biochem. 1980;7(4):291-338.
69. Hasday JD, Sitrin RJ. Dipyridamole stimulates urokinase production and suppresses procoagulant activity of rabbit alveolar macrophages: A possible mechanism of antithrombotic action. Blood. 1987;69:660.
70. Colli S, Tremoli E. Multiple effects of dipyridamole on neutrophils and mononuclear leukocytes: Adenosine-dependent and adenosine-independent mechanisms. J Lab Clin Med. 1991;118:126.
71. Aznar-Salatti J, Bastida E, Escolar G, Almirall L, Diaz-Ricart M, Anton P, Castillo R, Ordinas A. Dipyridamole induces changes in the thrombogenic properties of extracellular matrix produced by endothelial cell in culture. Thromb Res. 1991;64:341.
72. LeVraux V, et al. Inhibition of human monocyte TNF production by adenosine receptor agonists. Life Sci. 1993;52:1917.
73. Bronza JP, et al. Dipyridamole inhibits superoxide anion release and expression of tissue factor activity by peripheral blood monocytes stimulated with lipopolysaccharide. Thromb Res. 1990;60:141.
74. Suzuki S, Sugai K, Sato H, Sakatume M, Arakawa M. Inhibition of active oxygen generation by dipyridamole in human polymorphonuclear leukocytes. Eur J Pharmacol. 1992;227:395.